Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.
about
Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challengesDiscovery of the inhibitory effect of a phosphatidylinositol derivative on P-glycoprotein by virtual screening followed by in vitro cellular studiesGenome-Wide Association of Heroin Dependence in Han ChineseNeonatal abstinence syndrome after methadone or buprenorphine exposureA polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependenceGenome-wide association data suggest ABCB1 and immune-related gene sets may be involved in adult antisocial behaviorThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Decision-making in stimulant and opiate addicts in protracted abstinence: evidence from computational modeling with pure users.Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence.Voluntary wheel running produces resistance to inescapable stress-induced potentiation of morphine conditioned place preference.Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample.Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to humanIndividual differences in the effects of environmental stimuli on cocaine choice in socially housed male cynomolgus monkeys.BDNF Val(66)Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot studyThe endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?Aversive and reinforcing opioid effects: a pharmacogenomic twin study.Opiate drug use and the pathophysiology of neuroAIDS.Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populationsOpiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.Opiate versus psychostimulant addiction: the differences do matterThe genetics of the opioid system and specific drug addictionsBiomarkers for the development of new medications for cocaine dependence.Association study of the β-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European-American population.Genetic variants associated with addictive behavior in Colombian addicted and non-addicted to heroin or cocaine.Methadone: a review of drug-drug and pathophysiological interactions.Translational genetic approaches to substance use disorders: bridging the gap between mice and humans.OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis.Possible role of a dysregulation of the endogenous opioid system in antisocial personality disorder.Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives.Global genetic variation of select opiate metabolism genes in self-reported healthy individuals.The worldwide opioid epidemic: implications for treatment and research in pregnancy and the newborn.Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional Clinician Improving Focus, Motivation and Overall Sensory Input Following Chronic Intake.Genetic moderation of cocaine subjective effects by variation in the TPH1, TPH2, and SLC6A4 serotonin genes.Biochemical Diagnosis in Substance and Non-substance Addiction.Association of haplotype combination of serotonin transporter gene polymorphisms with monthly headache days in MOH patients.Evaluation of prodynorphin gene polymorphisms and their association with heroin addiction in a sample of the southeast Iranian population.Enkephalin as a Pivotal Player in Neuroadaptations Related to Psychostimulant Addiction.Opioid Receptors Gene Polymorphism and Heroin Dependence in Iran.
P2860
Q24627422-0DD3F01C-9914-4CD4-9514-B0408EDFC7FDQ28486121-A32073C0-8275-4529-AAE3-0E2EA79016DFQ28554877-2910AED6-BB8F-4589-970F-9910BC362AB7Q30499416-2B747531-EE63-4451-8862-102728958FB7Q30855550-DE640422-1A98-45F0-955B-BA1EBB3F91A1Q30940186-CE01F954-AF2B-472D-A507-663D6A623A1EQ33870389-69ADF860-2F93-4EE0-B940-16A05757BBD0Q34030618-EFB15AB3-492B-40D4-88A0-50ADD1A770F7Q34139876-5F4788D3-AA42-4B40-88E7-4E4AF75FF61CQ34708659-4148251D-2171-48C4-9A1B-94B1B3399C53Q35005588-CE252D56-3E85-410D-B23C-A9212CB62929Q35007339-BDA179D5-BECF-4310-B585-38E6087E7C33Q35083939-F3E649E9-13BC-4497-8C1F-B656D899B85BQ35589969-1026AD04-7F22-4818-A820-807ACEC498E9Q35889204-69E3D3F0-AEC8-4332-9DD4-96162DB6818CQ35987786-DF2531C3-97FC-4E56-9233-C401F7D993DBQ36110480-BEAA03FA-9FBC-4A1B-9462-3EDD11770521Q36191409-E2E2678A-B8EE-45E4-972E-38C5DCABA71EQ36201412-C9B4FD8C-8E02-4AB7-B2E9-C0CFADF82FE9Q36431241-B41CC9BA-EA8C-4329-AD1F-72A79F91A349Q36499673-D0D5BEB3-74FA-445E-8ECC-7B8B4FB1FAD9Q37039781-3E89D5DB-7734-4DAA-8028-0C965BFD024AQ37040492-64420738-FDBD-46A7-9EB1-414D419BF083Q37379480-48F4F12C-BE84-4542-A3B5-59963DE2092AQ37576232-818BD7CE-8808-4429-B16F-3ED492107267Q37727486-EA483C86-625E-4A6C-B723-8C258259C041Q37950478-971B3E8B-561A-4DAD-9BF3-05B5BF46085CQ37968513-E70F056E-3274-4C33-904F-A701C86FCEBDQ38104745-223FE3FF-7BDC-41AE-B40C-4ACA1FCA3026Q38562081-6534DF73-4F1D-424E-B890-650007B636E4Q38608450-05C983E1-C74F-4771-BF73-557D6A08A2C8Q38731965-5E0C3D47-4B9C-4B59-80B5-D49C91E60BA6Q44330446-D721C00B-BDEF-494C-BBC6-F3A2755C4DC5Q47142976-E343E50F-C1BB-41F4-9D96-7D10931344E4Q47863987-4CBC7393-E002-4C4C-B2D7-367C80DE8A8CQ52314530-A4E38048-2CCD-405F-B74F-B4679FC76CE3Q54372608-C8D053D6-390C-4E31-9CD6-B8185704AC5FQ55080869-70A2D172-1530-4206-AE53-207E5C39A649Q55266051-A9B7FE6C-AA49-42C2-9CE3-550146851C29Q55438611-8AC39F49-D039-4B3A-A7FB-6C3B7BF8E408
P2860
Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Search for genetic markers and ...... caine addiction and treatment.
@en
Search for genetic markers and ...... caine addiction and treatment.
@nl
type
label
Search for genetic markers and ...... caine addiction and treatment.
@en
Search for genetic markers and ...... caine addiction and treatment.
@nl
prefLabel
Search for genetic markers and ...... caine addiction and treatment.
@en
Search for genetic markers and ...... caine addiction and treatment.
@nl
P2093
P2860
P1476
Search for genetic markers and ...... caine addiction and treatment.
@en
P2093
David A Nielsen
Dmitri Proudnikov
Orna Levran
Vadim Yuferov
P2860
P304
P356
10.1111/J.1749-6632.2009.05275.X
P407
P577
2010-02-01T00:00:00Z